Tuesday, May 16 2023
10:15 AM – 10:40 AM PT
Enrolling a Full Clinical Trial/Conventional Clinical Trial Design
Rae Blaylark. Sickle Cell Foundation of Minnesota, Minneapolis, MN
Disclosures: R. Blaylark: 1; Commercial Interest i.e. Company X; Agios Pharmaceuticals. 1; What was received? i.e. Honorarium; Stipend, Event Sponsorship. 1; For what role? i.e. Speaker; Patient Advisory Board, Event Sponsorship. 2; Commercial Interest i.e. Company X; Beam Therapeutics. 2; What was received? i.e. Honorarium; Stipend, Event Sponsorship. 2; For what role? i.e. Speaker; Patient Advisory Board, Event Sponsorship. 3; Commercial Interest i.e. Company X; BlueBird Bio. 3; What was received? i.e. Honorarium; Stipend. 3; For what role? i.e. Speaker; Patient Advisory Board. 4; Commercial Interest i.e. Company X; Emmaus. 4; What was received? i.e. Honorarium; Event Sponsorship. 4; For what role? i.e. Speaker; Event Sponsorship. 5; Commercial Interest i.e. Company X; Novo Nordisk. 5; What was received? i.e. Honorarium; Stipend, Honorarium. 5; For what role? i.e. Speaker; Patient Advisory Board, Speaker. 6; Commercial Interest i.e. Company X; Global Blood Therapeutics. 6; What was received? i.e. Honorarium; Stipend. 6; For what role? i.e. Speaker; Patient Advisory Board.